Tom Aken is the founder of Avantium. Backed by Shell, GlaxoSmithKline, Pfizer. Based in Amsterdam, Netherlands.
Tom van Aken is the CEO of Avantium, a company focused on renewable chemistry. He joined Avantium in 2002 and became CEO in 2005, making him one of the longest-serving CEOs in the Netherlands. Under his leadership, Avantium has shifted its focus to using renewable feedstocks for a more sustainable and circular economy.
Full founder directory · Investor directory · Company funding database · Fundraising library